Industry Implications of AI: Thought Leaders in Health Law Video SeriesMay 30, 2018
In this Thought Leaders in Health Law® video, Gail H. Javitt, Robert E. Wanerman, Joshua J. Freemire, and Alaap B. Shah, Members of the Firm in the Health Care and Life Sciences practice, discuss the legal implications and concerns that have arisen from the adoption of artificial intelligence (AI) by the health care and life sciences industry.
This video examines the following:
- The powerful impact AI will have in assisting health care providers and other health care companies in meeting the “Triple Aim”—an approach to optimizing health system performance
- Ways to address the conflict between AI technologies and the current regulatory paradigms at the Food and Drug Administration, the Centers for Medicare & Medicaid Services, and other government agencies
- How the very nature of AI creates risk and questions about where liability for patient care rests
- What the successful adoption of AI might look like for the health care and life sciences industry of the future
A multifaceted team of Epstein Becker Green’s health care and life sciences, privacy and security, and employment, labor, and workforce management attorneys can assist health care companies, as well as employers across industries, in successfully adopting AI into their organizations while minimizing legal risk.
The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.
Trouble viewing the video? Please contact Kelli Sakalousky at [email protected] and mention whether you were at home or working within a corporate network. We'd also love your suggestions for future topics. Subscribe to our Health Care and Life Sciences email list to be notified of future video releases.
THOUGHT LEADERS IN HEALTH LAW® is a registered trademark of Epstein Becker & Green, P.C.